Abraxas Petro Corp (AXAS)

1.84  -0.1 (-5.15%)

After market: 1.86 +0.02 (+1.09%)

Fundamental Rating

0

AXAS gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 214 industry peers in the Oil, Gas & Consumable Fuels industry. AXAS may be in some trouble as it scores bad on both profitability and health. AXAS does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

AXAS had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -180.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -374.64%
PM (TTM) -567.57%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

There is no outstanding debt for AXAS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -13.23, we must say that AXAS is in the distress zone and has some risk of bankruptcy.
AXAS has a Debt/Equity ratio of -0.03. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.03
Debt/FCF N/A
Altman-Z -13.23
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

AXAS has a Current Ratio of 0.08. This is a bad value and indicates that AXAS is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.08 indicates that AXAS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08

0

3. Growth

3.1 Past

AXAS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -149000.00%.
Measured over the past years, AXAS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -36.58% on average per year.
Looking at the last year, AXAS shows a very negative growth in Revenue. The Revenue has decreased by -60.14% in the last year.
Measured over the past years, AXAS shows a decrease in Revenue. The Revenue has been decreasing by -8.48% on average per year.
EPS 1Y (TTM)-149000%
EPS 3Y-42.26%
EPS 5Y-36.58%
EPS growth Q2Q-158.96%
Revenue 1Y (TTM)-60.14%
Revenue growth 3Y-20.68%
Revenue growth 5Y-8.48%
Revenue growth Q2Q6%

3.2 Future

Based on estimates for the next years, AXAS will show a very negative growth in Earnings Per Share. The EPS will decrease by -34.73% on average per year.
Based on estimates for the next years, AXAS will show a very negative growth in Revenue. The Revenue will decrease by -23.81% on average per year.
EPS Next Y0%
EPS Next 2Y-53.96%
EPS Next 3Y-43.38%
EPS Next 5Y-34.73%
Revenue Next Year29.96%
Revenue Next 2Y-45.16%
Revenue Next 3Y-31.89%
Revenue Next 5Y-23.81%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

AXAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AXAS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.55

4.3 Compensation for Growth

AXAS's earnings are expected to decrease with -43.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-53.96%
EPS Next 3Y-43.38%

0

5. Dividend

5.1 Amount

No dividends for AXAS!.
Industry RankSector Rank
Dividend Yield N/A

Abraxas Petro Corp

NASDAQ:AXAS (8/3/2021, 7:00:00 PM)

After market: 1.86 +0.02 (+1.09%)

1.84

-0.1 (-5.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap15.50M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -180.52%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -374.64%
PM (TTM) -567.57%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity -0.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-149000%
EPS 3Y-42.26%
EPS 5Y
EPS growth Q2Q
EPS Next Y0%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-60.14%
Revenue growth 3Y-20.68%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y